Sign in
4/A

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-16-046997

Options or other derivatives

  • President & CEO acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Murray Mark J. · President & CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-07-09 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc1.xml…